Crucial areas of the economic analysis of public cancer care
Open Access
- 18 February 2020
- journal article
- research article
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 12 (4) , 310-317-317
Abstract
Introduction. The economic aspects of providing cancer care to the public attract increasing attention of scientists, economists, physicians and other healthcare professionals. Currently, the healthcare economics of oncological institutions is defined as part of the national economy that implements cancer care programs and provide a wide range of medical and pharmaceutical services to the public.Aim. The study was conducted as part of the program for improvement of financial spending in order to facilitate cancer care for Moscow residents. The aim of this study was to identify the crucial areas of the cost analysis and thus improve the public health service.Materials and methods. We used the methodology of targeted and consistent search of the literature. The data search and analysis was carried out using the US National Medical Library (PubMed database), National Electronic Library (e-LIBRARY, Russia), and other Internet resources. Whenever possible, articles on the most common and socially significant types of cancer (breast, colon, prostate, lung etc.) were selected. In addition, we focused on significant studies conducted either on the national or international level.Results and discussion. In principle, the structure of total costs is determined by the health policy regarding the cancer care system. Six main areas of oncological care that require careful economic analysis have been identified: those are prevention, oncoscreening, diagnosis, treatment, rehabilitation, and palliative care. In order to implement the economic goals of the healthcare system, the cost of cancer treatment should be discussed. The relevant programs are expected to be based on 1) prevalence and incidence; 2) impact on health; 3) results of the integrative methodological approach to cancer treatment; 4) implementation of comprehensive measures of medical and social assistance; 5) use of financial mechanisms and their impact on economic indicators.Conclusion. The set of measures related to the direct costs as identified in this study include the development, planning and provision of cancer care. These specific features of the direct cost analysis are important for organizing medical care in oncological institutions.Keywords
This publication has 29 references indexed in Scilit:
- Real-World Clinical and Economic Outcomes and the Role of Bevacizumab in Patients With Non–Small-Cell Lung Cancer With Liver MetastasesJournal of Oncology Practice, 2019
- Cost of Cancer: Healthcare Expenditures and Economic Impact2018
- Estimation of Socioeconomic Burden of Lung Cancer in the Russian FederationMedical Technologies. Assessment and Choice, 2018
- The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control2015
- Model-Based Analyses to Compare Health and Economic Outcomes of Cancer Control: Inclusion of DisparitiesJNCI: Journal of the National Cancer Institute, 2011
- When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in OncologyJNCI: Journal of the National Cancer Institute, 2010
- The global burden of cancer: priorities for preventionCarcinogenesis, 2009
- Economics of Cancer CareJournal of Oncology Practice, 2007
- The Economics of Cancer Care2006
- Disease cases and their medical costs attributable to smoking: an analysis of the national medical expenditure surveyJournal of Econometrics, 2003